Form 6-K INSTINCT BIO TECHNICAL For: Aug 10

August 10, 2026 11:05 AM EDT

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of August 2026

 

Commission File Number: 001-43415

 

Instinct Bio Technical Company Holdings Inc.

(Registrant’s Name)

 

3rd Floor West Side Gotanda bldg.

6-2-7 Nishi Gotanda, Shinagawa-ku,

Tokyo 1410031, Japan

(Address of Principal Executive Offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F x Form 40-F ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):¨

 

 

 

 

 

  

Information Contained in this Form 6-K Report

 

On August 10, 2026, Instinct Bio Technical Company Holdings Inc. (the “Company”) announced it had entered into a cooperation agreement with PT Parva Candela, an Indonesian cosmetics manufacturer and distributor, in respect of the joint development of Indonesia’s cosmetics and personal care market. A copy of the press release is attached hereto as Exhibit 99.1.

 

The information contained in this Report on Form 6-K, including Exhibit 99.1 furnished herewith, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing. 

 

 

INDEX TO EXHIBIT

 

Exhibit No.   Description
99.1   Press Release dated August 10, 2026

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Instinct Bio Technical Company Holdings Inc.
     
Date: August 10, 2026 By: /s/ Tomoki Nagano
  Name:  Tomoki Nagano
  Title: Chief Executive Officer and Director

 

 

 

 

 

ATTACHMENTS / EXHIBITS

EXHIBIT 99.1



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings